|
1
|
Wu WJ, Shen Y, Sui J, Li CY, Yang S, Xu
SY, Zhang M, Yin LH, Pu YP and Liang GY: Integrated analysis of
long noncoding RNA competing interactions revealed potential
biomarkers in cervical cancer: Based on a public database. Mol Med
Rep. 17:7845–7858. 2018.PubMed/NCBI
|
|
2
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin CL, Lee CH, Chen CM, Cheng CW, Chen
PN, Ying TH and Hsieh YH: Protodioscin induces apoptosis through
ROS-mediated endoplasmic reticulum stress via the JNK/p38
activation pathways in human cervical cancer cells. Cell Physiol
Biochem. 46:322–334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pranatharthi A, Thomas P, Udayashankar AH,
Bhavani C, Suresh SB, Krishna S, Thatte J, Srikantia N, Ross CR and
Srivastava S: RhoC regulates radioresistance via crosstalk of ROCK2
with the DNA repair machinery in cervical cancer. J Exp Clin Cancer
Res. 38:3922019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu C, Lin Q and Yun Z: Cellular and
molecular mechanisms underlying oxygen-dependent radiosensitivity.
Radiat Res. 183:487–496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hennessey D, Martin LM, Atzberger A, Lynch
TH, Hollywood D and Marignol L: Exposure to hypoxia following
irradiation increases radioresistance in prostate cancer cells.
Urol Oncol. 31:1106–1116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hong BJ, Kim J, Jeong H, Bok S, Kim YE and
Ahn GO: Tumor hypoxia and reoxygenation: The yin and yang for
radiotherapy. Radiat Oncol J. 34:239–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Candelaria M, Garcia-Arias A, Cetina L and
Duenas-Gonzalez A: Radiosensitizers in cervical cancer. Cisplatin
and beyond. Radiat Oncol. 1:152006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tamari K, Sano K, Li Z, Seo Y, Otani K,
Tatekawa S, Toratani M, Takaoka Y, Takahashi Y, Minami K, et al: Ro
90–7501 is a novel radiosensitizer for cervical cancer cells that
inhibits ATM phosphorylation. Anticancer Res. 39:4805–4810. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mabuchi S and Kimura T: Nedaplatin: A
radiosensitizing agent for patients with cervical cancer. Chemother
Res Pract. 2011:9631592011.PubMed/NCBI
|
|
11
|
Javvadi P, Segan AT, Tuttle SW and
Koumenis C: The chemopreventive agent curcumin is a potent
radiosensitizer of human cervical tumor cells via increased
reactive oxygen species production and overactivation of the
mitogen-activated protein kinase pathway. Mol Pharmacol.
73:1491–1501. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vaupel P: Oxygenation of human tumors.
Strahlenther Onkol. 166:377–386. 1990.PubMed/NCBI
|
|
13
|
Mayer R, Hamilton-Farrell MR, van der
Kleij AJ, Schmutz J, Granström G, Sicko Z, Melamed Y, Carl UM,
Hartmann KA, Jansen EC, et al: Hyperbaric oxygen and radiotherapy.
Strahlenther Onkol. 181:113–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Becker A, Kuhnt T, Liedtke H, Krivokuca A,
Bloching M and Dunst J: Oxygenation measurements in head and neck
cancers during hyperbaric oxygenation. Strahlenther Onkol.
178:105–108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brizel DM, Hage WD, Dodge RK, Munley MT,
Piantadosi CA and Dewhirst MW: Hyperbaric oxygen improves tumor
radiation response significantly more than carbogen/nicotinamide.
Radiat Res. 147:715–720. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hartmann KA, van der Kleij AJ, Carl UM,
Hulshof MC, Willers R and Sminia P: Effects of hyperbaric oxygen
and normobaric carbogen on the radiation response of the rat
rhabdomyosarcoma R1H. Int J Radiat Oncol Biol Phys. 51:1037–1044.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nordsmark M, Maxwell RJ, Horsman MR,
Bentzen SM and Overgaard J: The effect of hypoxia and hyperoxia on
nucleoside triphosphate/inorganic phosphate, pO2 and radiation
response in an experimental tumour model. Br J Cancer.
76:1432–1439. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pietrofesa RA, Velalopoulou A, Lehman SL,
Arguiri E, Solomides P, Koch CJ, Mishra OP, Koumenis C, Goodwin TJ
and Christofidou-Solomidou M: Novel double-hit model of radiation
and hyperoxia-induced oxidative cell damage relevant to space
travel. Int J Mol Sci. 17:9532016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hofer T, Desbaillets I, Hopfl G, Wenger RH
and Gassmann M: Characterization of HIF-1 alpha overexpressing HeLa
cells and implications for gene therapy. Comp Biochem Physiol C
Toxicol Pharmacol. 133:475–481. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JH, Yoon J and Park B: Pomolic acid
suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK
and mTOR signaling cascades. Phytomedicine. 23:1716–1726. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JY, Gu ZJ, Wu MX, Yang Y, Zhang JH,
Ou JS, Zuo ZY, Wang JF and Chen YX: C-reactive protein can
upregulate VEGF expression to promote ADSC-induced angiogenesis by
activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling
pathways. Stem Cell Res Ther. 7:1142016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyasaka A, Oda K, Ikeda Y, Sone K, Fukuda
T, Inaba K, Makii C, Enomoto A, Hosoya N, Tanikawa M, et al:
PI3K/mTOR pathway inhibition overcomes radioresistance via
suppression of the HIF1-α/VEGF pathway in endometrial cancer.
Gynecol Oncol. 138:174–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fechner G, Dederichs F, Schmidt D, Muller
S, Vaupel P and Albers P: Hyperoxia-induced improvement of the in
vitro response to gemcitabine in transitional cell carcinoma.
Anticancer Res. 25:3413–3418. 2005.PubMed/NCBI
|
|
25
|
Liu Q, He X, Liu Y, Du B, Wang X, Zhang W,
Jia P, Dong J, Ma J, Wang X, et al: NADPH oxidase-mediated
generation of reactive oxygen species: A new mechanism for
X-ray-induced HeLa cell death. Biochem Biophys Res Commun.
377:775–779. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu J, Suzuki T, Lu S and Suzuki N:
Involvement of glyceraldehyde-3-phosphate dehydrogenase in the
X-Ray resistance of HeLa cells. Biosci Biotechnol Biochem.
72:2432–2435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lake AC, Vassy R, Di Benedetto M, Lavigne
D, Visage CL, Perret GY and Letourneur D: Low molecular weight
fucoidan increases VEGF165-induced endothelial cell migration by
enhancing VEGF165 binding to VEGFR-2 and NRP1. J Biol Chem.
281:37844–37852. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu XJ, Zhu JW, Jing J, Xue D, Liu H, Zheng
M and Lu ZF: VEGF165 modulates proliferation, adhesion, migration
and differentiation of cultured human outer root sheath cells from
central hair follicle epithelium through VEGFR-2 activation in
vitro. J Dermatol Sci. 73:152–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Han Y, Tao J, Liu S, Yan C and Li
S: Cellular repressor of E1A-stimulated genes regulates vascular
endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling
pathway. Exp Cell Res. 317:2904–2913. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsuzuki T, Okada H, Shindoh H, Shimoi K,
Nishigaki A and Kanzaki H: Effects of the hypoxia-inducible
factor-1 inhibitor echinomycin on vascular endothelial growth
factor production and apoptosis in human ectopic endometriotic
stromal cells. Gynecol Endocrinol. 32:323–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Walsh CM, Chvanov M, Haynes LP, Petersen
OH, Tepikin AV and Burgoyne RD: Role of phosphoinositides in STIM1
dynamics and store-operated calcium entry. Biochem J. 425:159–168.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma S, Musa T and Bag J: Reduced stability
of mitogen-activated protein kinase kinase-2 mRNA and
phosphorylation of poly(A)-binding protein (PABP) in cells
overexpressing PABP. J Biol Chem. 281:3145–3156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin C, McGough R, Aswad B, Block JA and
Terek R: Hypoxia induces HIF-1alpha and VEGF expression in
chondrosarcoma cells and chondrocytes. J Orthop Res. 22:1175–1181.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fu Z, Chen D, Cheng H and Wang F:
Hypoxia-inducible factor-1α protects cervical carcinoma cells from
apoptosis induced by radiation via modulation of vascular
endothelial growth factor and p53 under hypoxia. Med Sci Monitor.
21:318–325. 2015. View Article : Google Scholar
|
|
35
|
Shibuya M: VEGF-VEGFR system as a target
for suppressing inflammation and other diseases. Endocr Metab
Immune Disord Drug Targets. 15:135–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gupta AK, Bakanauskas VJ, Cerniglia GJ,
Cheng Y, Bernhard EJ, Muschel RJ and McKenna WG: The Ras radiation
resistance pathway. Cancer Res. 61:4278–4282. 2001.PubMed/NCBI
|
|
37
|
McKenna WG, Muschel RJ, Gupta AK, Hahn SM
and Bernhard EJ: The RAS signal transduction pathway and its role
in radiation sensitivity. Oncogene. 22:5866–5875. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shimura T, Kakuda S, Ochiai Y, Kuwahara Y,
Takai Y and Fukumoto M: Targeting the AKT/GSK3beta/cyclin D1/Cdk4
survival signaling pathway for eradication of tumor radioresistance
acquired by fractionated radiotherapy. Int J Radiat Oncol Biol
Phys. 80:540–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liao D and Johnson RS: Hypoxia: A key
regulator of angiogenesis in cancer. Cancer Metastasis Rev.
26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thomlinson RH and Gray LH: The
histological structure of some human lung cancers and the possible
implications for radiotherapy. Br J Cancer. 9:539–549. 1955.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bennett MH, Feldmeier J, Smee R and
Milross C: Hyperbaric oxygenation for tumour sensitisation to
radiotherapy. Cochrane Database Syst Rev. 4:CD0050072018.PubMed/NCBI
|
|
43
|
Gorski DH, Beckett MA, Jaskowiak NT,
Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM,
Kufe DW and Weichselbaum RR: Blockage of the vascular endothelial
growth factor stress response increases the antitumor effects of
ionizing radiation. Cancer Res. 59:3374–3378. 1999.PubMed/NCBI
|
|
44
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hiratsuka S, Minowa O, Kuno J, Noda T and
Shibuya M: Flt-1 lacking the tyrosine kinase domain is sufficient
for normal development and angiogenesis in mice. Proc Natl Acad Sci
USA. 95:9349–9354. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Selvaraj D, Gangadharan V, Michalski CW,
Kurejova M, Stösser S, Srivastava K, Schweizerhof M, Waltenberger
J, Ferrara N, Heppenstall P, et al: A functional role for VEGFR1
expressed in peripheral sensory neurons in cancer pain. Cancer
Cell. 27:780–796. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ding ZY, Huang YJ, Tang JD, Li G, Jiang PQ
and Wu HT: Silencing of hypoxia-inducible factor-1α promotes
thyroid cancer cell apoptosis and inhibits invasion by
downregulating WWP2, WWP9, VEGF and VEGFR2. Exp Ther Med.
12:3735–3741. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gupta VK, Jaskowiak NT, Beckett MA,
Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E,
Pejovic M, Kufe DW, et al: Vascular endothelial growth factor
enhances endothelial cell survival and tumor radioresistance.
Cancer J. 8:47–54. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen YA, Tzeng DTW, Huang YP, Lin CJ, Lo
UG, Wu CL, Lin H, Hsieh JT, Tang CH and Lai CH: Antrocin sensitizes
prostate cancer cells to radiotherapy through inhibiting PI3K/AKT
and MAPK signaling pathways. Cancers (Basel). 11:342018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mazzatti DJ, Lee YJ, Helt CE, O'Reilly MA
and Keng PC: p53 modulates radiation sensitivity independent of p21
transcriptional activation. Am J Clin Oncol. 28:43–50. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee KB, Kim KR, Huh TL and Lee YM: Proton
induces apoptosis of hypoxic tumor cells by the p53-dependent and
p38/JNK MAPK signaling pathways. Int J Oncol. 33:1247–1256.
2008.PubMed/NCBI
|
|
52
|
Yoon TM, Kim SA, Lee DH, Lee JK, Park YL,
Lee KH, Chung IJ, Joo YE and Lim SC: EGR1 regulates
radiation-induced apoptosis in head and neck squamous cell
carcinoma. Oncol Rep. 33:1717–1722. 2015. View Article : Google Scholar : PubMed/NCBI
|
